INST CARDIOMETABOLISME NUTRITION ICAN - France 

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2014-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 13.915.311 0 1
2017 0 15.797.881 684.250 1
2014 0 5.988.941 385.151 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
UNIVERSITY OF BIRMINGHAM2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
AEPODIA1
ALLERGAN LIMITED1
ANTAROS MEDICAL AB1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASTRAZENECA AB1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRISTOLMYERS SQUIBB COMPANY CORP1
CARISTO DIAGNOSTICS LIMITED1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
CENTRE INTEGRE UNIVERSITAIRE DE SANTE ET DE SERVICES SOCIAUX DE L ESTRIECENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE1
CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III1
ECHOSENS1
ELI LILLY AND COMPANY LIMITED1
ELLEGAARD GOTTINGEN MINIPIGS AS1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER1
EXALENZ BIOSCIENCE1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA1
GENFIT1
GILEAD SCIENCES INC1
HISTOINDEX PTE1
IDOVEN 1903 SL1
IMT TRANSFERT1
INTERCEPT PHARMA EUROPE1
IXSCIENT LIMITED1
KOMPETENZNETZ VORHOFFLIMMERN EV1
LINKOPINGS UNIVERSITET1
LUXEMBOURG INSTITUTE OF HEALTH1
MEDIZINISCHE UNIVERSITAET WIEN1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
NORDIC BIOSCIENCE1
NORDIC BIOSCIENCE COMPOUND DEVELOPMENT1
NOVARTIS PHARMA1
NOVO NORDISK1
ONE WAY LIVER SL1
OREBRO UNIVERSITY1
OWKIN FRANCE1
PERSPECTUM DIAGNOSTICS1
PFIZER LIMITED1
PREVENTICUS1
RESEARCH TRIANGLE INSTITUTE1
RESOUNDANT INC1
SANOFIAVENTIS DEUTSCHLAND1
SERVICIO ANDALUZ DE SALUD1
SERVICIO MADRILENO DE SALUD1
SGS EXPRIMO NV1
SIEMENS1
SOMALOGIC INC1
SORBONNE UNIVERSITE1
ST VINCENZKRANKENHAUS1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TARTU ULIKOOL1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
THE GENERAL HOSPITAL CORPORATION1
THE UNIVERSITY OF NOTTINGHAM1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITA DEGLI STUDI DI MILANO1
UNIVERSITA DEGLI STUDI DI PALERMO1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITAET BERN1
UNIVERSITAETSKLINIKUM AACHEN1
UNIVERSITAETSKLINIKUM ESSEN1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT1
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITAIR ZIEKENHUIS ANTWERPEN1
UNIVERSITE CATHOLIQUE DE LOUVAIN1
UNIVERSITE D'ANGERS1
UNIVERSITE DE LIEGE1
UNIVERSITE LIBRE DE BRUXELLES1
UNIVERSITEIT MAASTRICHT1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF HOUSTON SYSTEM1
UNIVERSITY OF NEWCASTLE UPON TYNE1
WOW TECHNOLOGY1
YOURRHYTHMICS1

Constancy:

Total number of partners: 84
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 84
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-03-01Machine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation MAESTRIAparticipant13.915.31120
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2014-02-01"Therapeutic Beta-Lactam Monitoring for Stratified Treatment of hospital-acquired pneumonia, improved dose-dependent efficacy, decreased treatment duration, and prevention of emergence of resistance" MON4STRATparticipant5.988.94111